More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.27B
EPS
3.57
P/E ratio
13.5
Price to sales
2.07
Dividend yield
--
Beta
0.342754
Previous close
$49.36
Today's open
$48.77
Day's range
$47.50 - $48.84
52 week range
$42.62 - $71.07
show more
CEO
Ronald M. Lombardi
Employees
600
Headquarters
Tarrytown, NY
Exchange
New York Stock Exchange
Shares outstanding
47374522
Issue type
Common Stock
Consumer Staples
Consumer Products - Healthcare
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.
Zacks Investment Research • Oct 15, 2026

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market.
GlobeNewsWire • Oct 14, 2026

Best Value Stocks to Buy for October 1st
BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.
Zacks Investment Research • Oct 1, 2026

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
While 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfort TARRYTOWN, N.Y., Sept. 30, 2026 /PRNewswire/ -- Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared.
PRNewsWire • Sep 30, 2026

PBH vs. NEOG: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Sep 30, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow
Prestige Consumer Healthcare NYSE: PBH said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives.
MarketBeat • Sep 27, 2026

PBH or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
Zacks Investment Research • Sep 14, 2026

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Seeking Alpha • Sep 10, 2026

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m.
GlobeNewsWire • Sep 8, 2026

Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
Zacks Investment Research • Sep 2, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Prestige Consumer Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.